retatrutide safety trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Phase 3 Results: Trials,

Overall, on the primary outcome endpoint (HbA1c), exenatide, liraglutide, lixisenatide, benaglutide, dulaglutide, PEG loxenatide, and semaglutide scored 3, 4, 2, 1, 4, 4, and 6, respectively

Hair shedding during or after significant weight loss is often benign and self-resolving, but there are circumstances in which it warrants professional assessment

Like TRIUMPH-2, this trial was also double-blind

Efficacy of polyphenolic compounds for hair regeneration: a systematic review and meta-analysis

In some cases, hair restoration procedures such as FUE (Follicular Unit Extraction) or DHI (Direct Hair Implantation) may be considered by board-certified physicians or plastic surgeons

Some patients may eventually transition to lower maintenance doses after reaching their weight goal, though complete discontinuation typically leads to gradual weight regain